ArticleBreast cancer research : BCR2011

Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.

Sumit Parmar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.